Hepatitis B Vaccine (Recombinant) Completed Phase 4 Trials for Hepatitis B Chronic Infection Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02360592Combination Therapy With Interferon Plus Interleukin 2 and Hepatitis B Vaccine in Chronic Hepatitis B Patients
NCT02505009Efficacy of HBV Vaccine in Consolidation of Nucleos(t)Ide Analogues Therapy